OmniAb Reports Second Quarter 2023 Financial Results and Business Highlights

Go back to OmniAb Reports Second Quarter 2023 Financial Results and Business Highlights
LIGAND PHARMA (NASDAQ: LGND) Delayed: 298.41 -0.09 (0.03%)
Previous Close $298.50    52 Week High $139.79 
Open $300.44    52 Week Low $82.07 
Day High $302.44    P/E 693.98 
Day Low $296.08    EPS $0.43 
Volume 242,190       

(NASDAQ: OABI) Delayed: 4.79 -0.13 (2.64%)
Previous Close $4.92    52 Week High
Open $4.90    52 Week Low
Day High $5.00    P/E N/A 
Day Low $4.69    EPS
Volume 1,051,021